Dopaminergic suppression of brain deactivation responses during sequence learning

Journal of Neuroscience

Volumn 28, Issue 42, 2008, Pages 10687-10695

  Argyelan, Miklos ^a   Carbon, Maren ^a,b   Ghilardi, Maria Felice ^c   Feigin, Andrew ^a,b   Mattis, Paul ^a,b   Tang, Chengke ^a,b   Dhawan, Vijay ^a,b   Eidelberg, David ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

COMT genotype; Deactivation; Default mode network; Levodopa; Parkinson's disease; Sequence learning

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; LEVODOPA;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENOTYPE; HUMAN; LEARNING; MALE; MOTOR PERFORMANCE; NERVE POTENTIAL; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; AGED; BRAIN; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

AGED; BRAIN; DOPAMINE; FEMALE; HUMANS; LEARNING; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

EID: 54849411771     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2933-08.2008     Document Type: Article

References (46)

1. Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE (2003) Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 23:2008-2013.
2. Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, Kaplitt MG, Feigin A, Eidelberg D (2006) Network modulation in the treatment of Parkinson's disease. Brain 129:2667-2678.
3. Bates JF, Goldman-Rakic PS (1993) Prefrontal connections of medial motor areas in the rhesus monkey. J Comp Neurol 336:211-228.
4. Bertolino A, Blasi G, Latorre V, Rubino V, Rampino A, Sinibaldi L, Caforio G, Petruzzella V, Pizzuti A, Scarabino T, Nardini M, Weinberger DR, Dallapiccola B (2006) Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci 26:3918-3922.
5. Bertolino A, Di Giorgio A, Blasi G, Sambataro F, Caforio G, Sinibaldi L, Latorre V, Rampino A, Taurisano P, Fazio L, Romano R, Douzgou S, Popolizio T, Kolachana B, Nardini M, Weinberger DR, Dallapiccola B (2008) Epistasis between dopamine regulating genes identifies a nonlinear response of the human hippocampus during memory tasks. Biol Psychiatry 64:226-234.
6. Bilder RM, Volavka J, Lachman HM, Grace AA (2004) The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamaine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29:1943-1961.
7. Brown WD, Taylor MD, Roberts AD, Oakes TR, Schueller MJ, Holden JE, Malischke LM, DeJesus OT, Nickles RJ (1999) FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa. Neurology 53:1212-1218.
8. Brück A, Aalto S, Nurmi E, Bergman J, Rinne JO (2005) Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease. Neurobiol Aging 26:891-898.
9. Carbon M, Ghilardi MF, Feigin A, Fukuda M, Silvestri G, Mentis MJ, Ghez C, Moeller JR, Eidelberg D (2003) Learning networks in health and Parkinson's disease: reproducibility and treatment effects. Hum Brain Mapp 19:197-211.
10. Carbon M, Ma Y, Barnes A, Dhawan V, Chaly T, Ghilardi MF, Eidelberg D (2004) Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in parkinsonism. Neuroimage 21:1497-1507.
11. Carbon M, Felice Ghilardi M, Dhawan V, Eidelberg D (2007) Correlates of movement initiation and velocity in Parkinson's disease: a longitudinal PET study. Neuroimage 34:361-370.
12. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807-821.
13. Cohen MX, Krohn-Grimberghe A, Elger CE, Weber B (2007) Dopamine gene predicts the brain's response to dopaminergic drug. Eur J Neurosci 26:3652-3660.
14. Cools R (2006) Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 30:1-23.
15. Cools R, Sheridan M, Jacobs E, D'Esposito M (2007) Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory. J Neurosci 27:5506-5514.
16. Crino PB, Morrison JH, Hof PR (1993) Monoaminergic innervation of cingulate cortex. In: Neurobiology of cingulate cortex and limbic thalamus: a comprehensive handbook (Vogt BA, Gabriel M, eds), pp 285-310. Boston: Birkhauser.
17. Doyon J (2008) Motor sequence learning and movement disorders. Curr Opin Neurol 24:478-483.
18. Feigin A, Ghilardi MF, Carbon M, Edwards C, Fukuda M, Dhawan V, Margouleff C, Ghez C, Eidelberg D (2003) Effects of levodopa on motor sequence learning in Parkinson's disease. Neurology 60:1744-1749.
19. Foltynie T, Goldberg TE, Lewis SG, Blackwell AD, Kolachana BS, Weinberger DR, Robbins TW, Barker RA (2004) Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism. Mov Disord 19:885-891.
20. Gerfen CR (2000) Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci 23:S64-70.
21. Ghilardi MF, Eidelberg D, Silvestri G, Ghez C (2003) The differential effect of PD and normal aging on early explicit sequence learning. Neurology 60:1313-1319.
22. Gibbs SE, D'Esposito M (2005) Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation. Cogn Affect Behav Neurosci 5:212-221.
23. Goldberg TE, Weinberger DR (2004) Genes and the parsing of cognitive processes. Trends Cogn Sci 8:325-335.
24. Goto Y, Grace AA (2005) Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat Neurosci 8:805-812.
25. Grace AA, Floresco SB, Goto Y, Lodge DJ (2007) Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30:220-227.
26. Greicius MD, Krasnow B, Reiss AL, Menon V (2003) Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A 100:253-258.
27. Hirano S, Asanuma K, Ma Y, Tang C, Feigin A, Dhawan V, Carbon M, Eidelberg D (2008) Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci 28:4201-4209.
28. Kaasinen V, Nagren K, Hietala J, Oikonen V, Vilkman H, Farde L, Halldin C, Rinne JO (2000) Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease. Neurology 54:1482-1487.
29. Kaasinen V, Nurmi E, Brück A, Eskola O, Bergman J, Solin O, Rinne JO (2001) Increased frontal [18F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex. Brain 124:1125-1130.
30. Lagarias JC, Reeds JA, Wright MH, Wright PE (1998) Convergence properties of the Nelder-Mead simplex method in low dimensions. SIAM J Optimization 9:112-147.
31. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D (2002) A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 159:652-654.
32. Mattay VS, Callicott JH, Bertolino A, Heaton I, Frank JA, Coppola R, Berman KF, Goldberg TE, Weinberger DR (2000) Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage 12:268-275.
33. Meyer-Lindenberg A, Kohn PD, Kolachana B, Kippenhan S, McInerney-Leo A, Nussbaum R, Weinberger DR, Berman KF (2005) Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci 8:594-596.
34. Nakamura T, Ghilardi MF, Mentis M, Dhawan V, Fukuda M, Hacking A, Moeller JR, Ghez C, Eidelberg D (2001) Functional networks in motor sequence learning: abnormal topographies in Parkinson's disease. Hum Brain Mapp 12:42-60.
35. Nikoshkov A, Drakenberg K, Wang X, Horvath MC, Keller E, Hurd YL (2008) Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression. Proc Natl Acad Sci U S A 105:786-791.
36. Okubo Y, Olsson H, Ito H, Lofti M, Suhara T, Halldin C, Farde L (1999) PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457. Neuroimage 10:666-674.
37. Picard N, Strick PL (1996) Motor areas of the medial wall: a review of their location and functional activation. Cereb Cortex 6:342-353.
38. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL (2001) A default mode of brain function. Proc Natl Acad Sci U S A 98:676-682.
39. Rakshi JS, Uema T, Ito K, Bailey DL, Morrish PK, Ashburner J, Dagher A, Jenkins IH, Friston KJ, Brooks DJ (1999) Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease a 3D [18F]dopa-PET study. Brain 122:1637-1650.
40. Seamans JK, Yang CR (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74:1-58.
41. Tamás Kincses Z, Johansen-Berg H, Tomassini V, Bosnell R, Matthews PM, Beckmann CF (2008) Model-free characterization of brain functional networks for motor sequence learning using fMRI. Neuroimage 39:1950-1958.
42. Van Hoesen GW, Morecraft RJ, Vogt BA (1993) Connections of the monkey cingulate cortex. In: Neurobiology of cingulate cortex and limbic thalamus: a comprehensive handbook (Vogt BA, Gabriel M, eds), pp 249-284. Boston: Birkhauser.
43. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF (2007) Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 10:376-384.
44. West AR, Grace AA (2002) Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. J Neurosci 22:294-304.
45. Williams-Gray CH, Hampshire A, Robbins TW, Owen AM, Barker RA (2007) Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J Neurosci 27:4832-4838.
46. Williams-Gray CH, Hampshire A, Barker RA, Owen AM (2008) Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype. Brain 131:397-408.